• Users Online: 276
  • Print this page
  • Email this page
This article has been cited by
1Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature
Colin Anderson-Smits,Erin R. Baker,Ishan Hirji
Transplant Infectious Disease.2020;22(6)
[DOI]
2Risk factors and outcome of concurrent and sequential multiviral cytomegalovirus, Epstein–Barr virus, BK virus, adenovirus and other viral reactivations in transplantation
Beatrice Z. Sim,Kar Yee Yong,Monica A. Slavin,Michelle K. Yong
Current Opinion in Infectious Diseases.2022;35(6)536
[DOI]
3Molecular and immune interactions between ß- and ?-herpesviruses in the immunocompromised host
Yessica Sánchez-Ponce,Ezequiel M. Fuentes-Pananá
Journal of Leukocyte Biology.2022;112(1)79
[DOI]
4The Role of Coinfections in the EBV–Host Broken Equilibrium
Yessica Sánchez-Ponce,Ezequiel M. Fuentes-Pananá
Viruses.2021;13(7)1399
[DOI]
5Herpesvirus Screening in Childhood Hematopoietic Transplant Reveals High Systemic Inflammation in Episodes of Multiple Viral Detection and an EBV Association with Elevated IL-1ß, IL-8 and Graft-Versus-Host Disease
Moisés H. Rojas-Rechy,Félix Gaytán-Morales,Yessica Sánchez-Ponce,Iván Castorena-Villa,Briceida López-Martínez,Israel Parra-Ortega,María C. Escamilla-Núñez,Alfonso Méndez-Tenorio,Ericka N. Pompa-Mera,Gustavo U. Martinez-Ruiz,Ezequiel M. Fuentes-Pananá,Abigail Morales-Sánchez
Microorganisms.2022;10(8)1685
[DOI]